Ventyx Biosciences ( NASDAQ:VTYX – Free Report ) had its price target reduced by HC Wainwright from $54.00 to $52.00 in a research note published on Friday, Benzinga reports. They currently have a buy rating on the stock. A number of other analysts have also recently commented on VTYX. Credit Suisse Group assumed coverage on shares of Ventyx Biosciences in a research note on Wednesday, June 14th. They set an outperform rating and a $63.00 target price for the company. 500.com reiterated a reiterates rating on shares of Ventyx Biosciences in a research report on Friday, May 12th.

https://www.dailypolitical.com/2023/08/12/ventyx-biosciences-nasdaqvtyx-price-target-cut-to-52-00.html

#dailypolitical